Table 4. Recorded phosphate binder therapy during 4 – 6 months in patients who switched from SO to other binders (n = 199).
Phosphate binder after switch | Number of patients |
---|---|
PB monotherapy | |
Sevelamer | 108 |
Calcium acetate | 53 |
Lanthanum carbonate | 13 |
Ferric citrate | 2 |
PB dual therapy | |
Calcium acetate + sevelamer | 14 |
Calcium acetate + lanthanum carbonate | 5 |
Lanthanum carbonate + sevelamer | 3 |
Lanthanum carbonate + ferric citrate | 1 |
Total | 199 |
PB = phosphate binder; SO = sucroferric oxyhydrase.